| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7115ef17a0cce55f36229865e31ea6a0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-22 |
| filingDate |
1990-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1991-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_091f71919a7aabb96eca43e90b14d620
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cf667a02be3cd063bda996d0ab94e67 |
| publicationDate |
1991-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5013751-A |
| titleOfInvention |
(+) Suprofen esters and amides as opthalmic anti-inflammatory agents |
| abstract |
Disclosed are esters and amides of (+) suprofen, substantially free of the corresponding enantiomorp, (-) suprofen, having enhanced delivery characteristics on topical administration to the eye; also disclosed are pharmaceutical compositions comprising such (+) suprofen derivatives and methods of using them when indicated to achieve an anti-inflammatory effect on topical delivery to the eye. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010095940-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5886030-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008036682-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9530420-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4218718-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3827747-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2392258-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006116718-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2147679-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012044761-A1 |
| priorityDate |
1989-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |